These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3280560)

  • 1. Time course of clinical effects of carbamazepine: implications for mechanisms of action.
    Post RM
    J Clin Psychiatry; 1988 Apr; 49 Suppl():35-48. PubMed ID: 3280560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic effects of carbamazepine. Relationship to clinical response in affective illness.
    Post RM; Rubinow DR; Uhde TW; Ballenger JC; Linnoila M
    Arch Gen Psychiatry; 1986 Apr; 43(4):392-6. PubMed ID: 3954558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of beneficial effects of l-baclofen in affective disorder.
    Post RM; Ketter TA; Joffe RT; Kramlinger KL
    Int Clin Psychopharmacol; 1991; 6(4):197-207. PubMed ID: 1816278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitization and kindling perspectives for the course of affective illness: toward a new treatment with the anticonvulsant carbamazepine.
    Post RM
    Pharmacopsychiatry; 1990 Jan; 23(1):3-17. PubMed ID: 2179972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of carbamazepine on cerebrospinal fluid somatostatin.
    Rubinow DR; Post RM; Gold PW; Ballenger JC; Reichlin S
    Psychopharmacology (Berl); 1985; 85(2):210-3. PubMed ID: 2861620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical effects of carbamazepine: relationship to its mechanisms of action in affective illness.
    Post RM; Uhde TW; Rubinow DR; Ballenger JC; Gold PW
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(2-3):263-71. PubMed ID: 6137029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of action of anticonvulsants in affective disorders: comparisons with lithium.
    Post RM; Weiss SR; Chuang DM
    J Clin Psychopharmacol; 1992 Feb; 12(1 Suppl):23S-35S. PubMed ID: 1541715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended-release carbamazepine for acute bipolar mania: a review.
    Owen RT
    Drugs Today (Barc); 2006 May; 42(5):283-9. PubMed ID: 16801991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes.
    Weisler RH; Kalali AH; Ketter TA;
    J Clin Psychiatry; 2004 Apr; 65(4):478-84. PubMed ID: 15119909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressant effects of carbamazepine.
    Post RM; Uhde TW; Roy-Byrne PP; Joffe RT
    Am J Psychiatry; 1986 Jan; 143(1):29-34. PubMed ID: 3510572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of carbamazepine on noradrenergic mechanisms in affectively ill patients.
    Post RM; Rubinow DR; Uhde TW; Ballenger JC; Lake CR; Linnoila M; Jimerson DC; Reus V
    Psychopharmacology (Berl); 1985; 87(1):59-63. PubMed ID: 2997829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of carbamazepine on serum electrolytes in affectively ill patients.
    Joffe RT; Post RM; Uhde TW
    Psychol Med; 1986 May; 16(2):331-5. PubMed ID: 3726007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contingent tolerance to the anticonvulsant effects of carbamazepine: relationship to loss of endogenous adaptive mechanisms.
    Weiss SR; Clark M; Rosen JB; Smith MA; Post RM
    Brain Res Brain Res Rev; 1995 Mar; 20(3):305-25. PubMed ID: 7550363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of anticonvulsants in manic-depressive illness.
    Ballenger JC
    J Clin Psychiatry; 1988 Nov; 49 Suppl():21-5. PubMed ID: 3053672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbamazepine diminishes the sensitivity of the plasma arginine vasopressin response to osmotic stimulation.
    Gold PW; Robertson GL; Ballenger JC; Kaye W; Chen J; Rubinow DR; Goodwin FK; Post RM
    J Clin Endocrinol Metab; 1983 Nov; 57(5):952-7. PubMed ID: 6619270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mood stabilizers--past, present and future].
    Sümegi A
    Neuropsychopharmacol Hung; 2008 Mar; 10(1):31-42. PubMed ID: 18771018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mood disorders in the psychoneurologic borderland: three cases of responsiveness to carbamazepine.
    Kessler AJ; Barklage NE; Jefferson JW
    Am J Psychiatry; 1989 Jan; 146(1):81-3. PubMed ID: 2492164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of carbamazepine in psychiatric disorders.
    Birkhimer LJ; Curtis JL; Jann MW
    Clin Pharm; 1985; 4(4):425-34. PubMed ID: 2864160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbamazepine attenuates cocaine-induced increases in dopamine in the nucleus accumbens: an in vivo dialysis study.
    Baptista T; Weiss SR; Post RM
    Eur J Pharmacol; 1993 May; 236(1):39-42. PubMed ID: 8319744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.